Reid Huber, Ph.D.
“Third Rock’s strength lies in the intensity and passion with which we pursue complex and difficult therapeutic challenges.”
At Third Rock, Reid brings over 20 years of operating experience in the biotechnology industry to focus on the formation, development and strategy of our portfolio companies. Reid was a member of the founding scientific team at Incyte in 2002, and most recently served as the company’s Executive Vice President and Chief Scientific Officer. Prior to Incyte, Reid held positions of increasing responsibility at Dupont Pharmaceuticals and Bristol-Myers Squibb. He conducted his postdoctoral training at the National Institutes of Health.
Reid is particularly excited about initiatives at the firm that combine deep understandings of disease genetics, data science and translational medicine. He is consistently impressed with his colleague’s focus on leveraging emerging areas of high-potential science to create breakthrough medicines for patients.
- B.S., Molecular Genetics and Biochemistry, Murray State University
- Ph.D., Human Molecular Genetics, Washington University School of Medicine in St. Louis
- East Coast